---
document_datetime: 2023-09-21 19:03:14
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/preotact-epar-all-authorised-presentations_en.pdf
document_name: preotact-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3719621
conversion_datetime: 2025-12-17 08:26:42.120237
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
MA (EU) number

EU/1/06/339/003

(Invented)

name

Preotact

Strength

100 Âµg

Pharmaceutical

Form

Powder and solvent for solution for

injection

Route of

Administration

Subcutaneous use

Immediate

Packaging powder:

dual-chamber cartridge (glass) in

pre-filled pen;

solvent:

dual-chamber cartridge (glass) in

pre-filled pen

Content

(concentration)

1.61 mg (1.4

mg/ml)

Medicinal product no longer authorised

Pack size

2 pre-filled pens